» Articles » PMID: 19549906

Overexpression of DPAGT1 Leads to Aberrant N-glycosylation of E-cadherin and Cellular Discohesion in Oral Cancer

Overview
Journal Cancer Res
Specialty Oncology
Date 2009 Jun 25
PMID 19549906
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer cells are frequently characterized by aberrant increases in protein N-glycosylation and by disruption of E-cadherin-mediated adherens junctions. The relationship between altered N-glycosylation and loss of E-cadherin adhesion in cancer, however, remains unclear. Previously, we reported that complex N-glycans on the extracellular domains of E-cadherin inhibited the formation of mature adherens junctions. Here, we examined whether dysregulated N-glycosylation was one of the underlying causes for cellular discohesion in oral cancer. We show that dense cultures of human salivary epidermoid carcinoma A253 cells exhibited elevated expression of DPAGT1, the gene that initiates protein N-glycosylation. Overexpression of DPAGT1 correlated with the production of E-cadherin-bearing complex N-glycans in nascent adherens junctions. Partial inhibition of DPAGT1 with small interfering RNA reduced the complex N-glycans of E-cadherin and increased the abundance of alpha-catenin and stabilizing proteins in adherens junctions. This was associated with the assembly of functional tight junctions. The inverse relationship between DPAGT1 expression and intercellular adhesion was a feature of oral squamous cell carcinoma. Oral squamous cell carcinomas displayed overexpression of DPAGT1 that correlated with diminished localization of E-cadherin and alpha-catenin at the sites of adherens junctions. Our studies show for the first time that DPAGT1 is an upstream regulator of E-cadherin N-glycosylation status and adherens junction composition and suggest that dysregulation of DPAGT1 causes disturbances in intercellular adhesion in oral cancer.

Citing Articles

Results from a real-world study: a novel glycosyltransferase risk score for prognosis, tumor microenvironment phenotypes and immunotherapy in bladder cancer.

Liu R, Yang T, Huang J, Xiao Z, Liu J, Li Z BMC Cancer. 2024; 24(1):947.

PMID: 39095785 PMC: 11297740. DOI: 10.1186/s12885-024-12712-w.


Inhibition of DPAGT1 suppresses HER2 shedding and trastuzumab resistance in human breast cancer.

Yang M, Li Y, Kong L, Huang S, He L, Liu P J Clin Invest. 2023; 133(14).

PMID: 37463446 PMC: 10348774. DOI: 10.1172/JCI164428.


Integrative Proteomics and Transcriptomics Profiles of the Oviduct Reveal the Prolificacy-Related Candidate Biomarkers of Goats () in Estrous Periods.

Sun Z, Liu Y, He X, Di R, Wang X, Ren C Int J Mol Sci. 2022; 23(23).

PMID: 36499219 PMC: 9737051. DOI: 10.3390/ijms232314888.


A genome-wide CRISPR screen identifies DPM1 as a modifier of DPAGT1 deficiency and ER stress.

Dalton H, Viswanatha R, Brathwaite Jr R, Zuno J, Berman A, Rushforth R PLoS Genet. 2022; 18(9):e1010430.

PMID: 36166480 PMC: 9543880. DOI: 10.1371/journal.pgen.1010430.


Glycoprotein α-Subunit of Glucosidase II (GIIα) is a novel prognostic biomarker correlated with unfavorable outcome of urothelial carcinoma.

Lin Q, Pei L, Zhao Z, Zhuang X, Qin H BMC Cancer. 2022; 22(1):817.

PMID: 35879690 PMC: 9316353. DOI: 10.1186/s12885-022-09884-8.


References
1.
Tanaka N, Odajima T, Ogi K, Ikeda T, Satoh M . Expression of E-cadherin, alpha-catenin, and beta-catenin in the process of lymph node metastasis in oral squamous cell carcinoma. Br J Cancer. 2003; 89(3):557-63. PMC: 2394393. DOI: 10.1038/sj.bjc.6601124. View

2.
Zhao Y, Takahashi M, Gu J, Miyoshi E, Matsumoto A, Kitazume S . Functional roles of N-glycans in cell signaling and cell adhesion in cancer. Cancer Sci. 2008; 99(7):1304-10. PMC: 11158068. DOI: 10.1111/j.1349-7006.2008.00839.x. View

3.
Wheelock M, Johnson K . Cadherins as modulators of cellular phenotype. Annu Rev Cell Dev Biol. 2003; 19:207-35. DOI: 10.1146/annurev.cellbio.19.011102.111135. View

4.
Diniz-Freitas M, Garcia-Caballero T, Antunez-Lopez J, Gandara-Rey J, Garcia-Garcia A . Reduced E-cadherin expression is an indicator of unfavourable prognosis in oral squamous cell carcinoma. Oral Oncol. 2005; 42(2):190-200. DOI: 10.1016/j.oraloncology.2005.07.010. View

5.
Birchmeier W, Behrens J . Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochim Biophys Acta. 1994; 1198(1):11-26. DOI: 10.1016/0304-419x(94)90003-5. View